Barclays PLC
17 February 2003
17 February 2003
Notification of directors' interests: Companies Act s329
The following directors of Barclays PLC notified the Company on 14 February 2003
that they purchased on 14 February 2003 the following ordinary shares in
Barclays PLC at a price of 374.25p per share:
DIRECTOR BARCLAYS PLC TOTAL BENEFICIAL INTEREST TOTAL
SHARES FOLLOWING THIS NON-BENEFICIAL INTEREST
PURCHASED NOTIFICATION FOLLOWING THIS
NOTIFICATION
T D G Arculus 1,709 13,100 -
H M Cropper 1,876 11,579 -
Sir Brian Jenkins 593 4,169 105,200
Sir Nigel Mobbs 1,817 48,144 20,000
Sir Nigel Rudd 1,658 10,262 -
S G Russell 1,939 9,064 -
G M Wallace 1,767 5,471 -
Dr J Zech 1,361 3,861 -
In addition to the interests shown above, the trustees of all the Barclays Group
employees' benefit trusts hold a total of 70,651,234 ordinary shares in Barclays
PLC. Sir Peter Middleton, Mr M W Barrett, Mr C J Lendrum, Mr J M Stewart and Mr
J S Varley, directors of Barclays PLC, are amongst the potential beneficiaries
under these trusts and are therefore regarded for Companies Act purposes as
being interested in the Barclays PLC ordinary shares.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.